Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
News and opinions on the latest ESC Clinical Practice Guidelines.
1. Preamble2. Introduction 2.1. Why do we need new guidelines on valvular heart disease? 2.2. Content of these guidelines 2.3. New format of the guidelines 2.4 How to use these guidelines 3. General comments 3.1 Patient evaluation 3.2 Risk stratification 3.3 Special considerations in elderly patients 3.4 Endocarditis prophylaxis 3.5 Prophylaxis for rheumatic fever 3.6 Concept of the Heart Team and heart valve centres 3.7 Management of associated conditions4. Aortic regurgitation 4.1 Evaluation 4.2 Indications for intervention 4.3. Medical therapy 4.4 Serial testing 4.5 Special patient populations 5. Aortic stenosis 5.1 Evaluation 5.2 Indications for intervention 5.3 Medical therapy 5.4 Serial testing 5.5 Special patient populations 6. Mitral regurgitation 37 6.1 Primary mitral regurgitation 6.2 Secondary mitral regurgitation 7. Mitral stenosis 7.1 Evaluation 7.2 Indications for intervention 7.3 Medical therapy 7.4 Serial testing 7.5 Special patient populations 8. Tricuspid regurgitation 8.1. Evaluation 8.2. Indications for intervention 9. Tricuspid stenosis 9.1 Evaluation 9.2 Indications for intervention 9.3 Medical therapy 10. Combined and multiple valve diseases 11. Prosthetic valves 11.1 Choice of prosthetic valve 5 11.2 Management after valve intervention 12. Management during non-cardiac surgery 12.1 Preoperative evaluation 12.2 Specific valve lesions 12.3 Perioperative monitoring13. Management during pregnancy 13.1 Native valve disease 13.2 Prosthetic valvesAppendixReferences
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.